New Prostate Cancer Treatment Reduces Side Effects
新型攝護腺癌治療法可減少副作用
更新於: 2026年9月30日 上午12:15
By 2026, the landscape of prostate cancer treatment has undergone a significant transformation, shifting away from aggressive, one-size-fits-all procedures toward precision medicine.
到了2026年，攝護腺癌的治療環境已產生了顯著的轉變，從過去激進、統一規格的醫療程序，轉向了精準醫學。
The primary goal for modern oncologists is no longer just survival; it is maintaining a high quality of life.
現代腫瘤科醫生的首要目標不再僅僅是存活；而是維持高品質的生活。
Similarly, Focal Therapy treatments, such as HIFU, allow doctors to target only the cancerous tissue, sparing the rest of the gland and preserving daily function.
同樣地，像HIFU這類局部治療，讓醫生得以只鎖定癌變組織，保留腺體其餘部分並維持日常功能。
For many, prostate cancer is increasingly viewed as a manageable chronic condition.
對許多人而言，攝護腺癌正越來越多地被視為一種可控的慢性病。
By utilizing genetic testing and AI-enhanced imaging, clinicians can tailor treatments to the individual, ensuring that the burden of therapy is minimized.
透過基因檢測和人工智慧增強影像技術，臨床醫生能針對個人量身打造治療方案，確保將治療帶來的負擔減至最低。
This patient-centered approach marks a new era where quality of life stands at the heart of successful cancer care.
這種以病患為中心的醫療方式，標誌著一個新時代的來臨，在這個時代中，生活品質是成功癌症照護的核心。
